Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2625 to 2674 of 8289 in total 
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1313\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60 kda heat shock protein, mitochondrial precursor (hsp60) (60 kda chaperonin) (cpn60) (heat shock protein 60) (hsp-60) (mitochondrial matrix protein p1) (p60 lymphocyte protein) (hucha60). [source:swissprot;acc:p10809]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5457.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5899.85\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08112\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
programmed cell death protein 6 (probable calcium-binding protein alg- 2). [source:swissprot;acc:o75340]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7996.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8279.04\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03527\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1314\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
j domain protein c21orf55. [source:swissprot;acc:q9nx36]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8264.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8556.26\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03526\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar protein sorting-associated protein 45 (h-vps45) (hlvps45). [source:swissprot;acc:q9nrw7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5401.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5838.63\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08095\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1315\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
apolipoprotein a-i binding protein; apoa-i binding protein. [source:refseq;acc:nm\_144772]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8286.86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8578.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03525\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
dna polymerase gamma subunit 1 (ec 2.7.7.7) (mitochondrial dna polymerase catalytic subunit) (polg-alpha). [source:swissprot;acc:p54098]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5685.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6145.43\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08084\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1316\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
orphan nuclear receptor nr2e1 (nuclear receptor tlx) (tailless homolog) (tll) (htll). [source:swissprot;acc:q9y466]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6105.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6599.41\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08082\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative dynein light chain protein dj8b22.1. [source:swissprot;acc:q9y3p0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8015.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8298.41\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03524\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1317\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
orphan nuclear receptor tr2. [source:swissprot;acc:p13056]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6105.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6599.06\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0808\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
topoisomerase-related function protein 4-2. [source:refseq;acc:nm\_022447]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7944.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8224.05\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03523\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1318\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
probable atp-dependent helicase ddx35 (deah-box protein 35). [source:swissprot;acc:q9h5z1]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7610.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7878.8\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase nek1 (ec 2.7.1.37) (nima-related protein kinase 1) (ny-ren-55 antigen). [source:swissprot;acc:q96py6]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5961.97\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6443.07\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.08069\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1319\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase nek3 (ec 2.7.1.37) (nima-related protein kinase 3) (hspk 36). [source:swissprot;acc:p51956]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
translocation protein 1; dtrp1 protein; membrane protein sec62, s.cerevisiae, homolog of. [source:refseq;acc:nm\_003262]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7856.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8132.83\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03523\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1320\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glyceraldehyde 3-phosphate dehydrogenase, liver (ec 1.2.1.12) (gapdh). [source:swissprot;acc:p04406]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5961.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6443.07\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08069\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine--pyruvate aminotransferase (ec 2.6.1.51) (spt) (alanine-- glyoxylate aminotransferase) (ec 2.6.1.44) (agt). [source:swissprot;acc:p21549]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8265.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8556.37\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03522\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1321\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
suppressor of var1, 3-like 1. [source:refseq;acc:nm\_003171]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6439.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6959.21\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08066\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tubulin tyrosine ligase-like protein hottl (hqp0207). [source:swissprot;acc:q9y4r7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7859.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8136.03\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03522\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1322\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
bag-family molecular chaperone regulator-1 (bcl-2 binding athanogene- 1) (bag-1) (glucocorticoid receptor-associated protein rap46). [source:swissprot;acc:q99933]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6439.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6959.21\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08066\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein nkx-2.3 (homeobox protein nkx-2.3) (homeobox protein nk-2 homolog c). [source:swissprot;acc:q8tau0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7732.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8004.48\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03522\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1323\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen synthase kinase-3 alpha (ec 2.7.1.37) (gsk-3 alpha). [source:swissprot;acc:p49840]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6439.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6959.21\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08066\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein nkx-2.5 (homeobox protein nk-2 homolog e) (cardiac- specific homeobox) (homeobox protein csx). [source:swissprot;acc:p52952]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7732.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8005.05\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0352\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1324\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
collagen alpha 2(vi) chain precursor. [source:swissprot;acc:p12110]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7757.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8030.19\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen synthase kinase-3 beta (ec 2.7.1.37) (gsk-3 beta). [source:swissprot;acc:p49841]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6439.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6959.21\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08066\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1325\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
limkain beta 2. [source:refseq;acc:nm\_025140]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7891.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8168.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0352\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2b catalytic subunit, alpha isoform (ec 3.1.3.16) (calmodulin-dependent calcineurin a subunit, alpha isoform) (cam-prp catalytic subunit). [source:swissprot;acc:q08209]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5656.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6112.02\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.08047\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1326\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial gtp binding protein isoform v. [source:refseq;acc:nm\_032620]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6222.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6723.54\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative protein-tyrosine phosphatase tpte (ec 3.1.3.48). [source:swissprot;acc:p56180]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8003.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8285\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03519\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1327\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
p protein (melanocyte-specific transporter protein). [source:swissprot;acc:q04671]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5656.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6111.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08045\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tpte and pten homologous inositol lipid phosphatase. [source:refseq;acc:nm\_130785]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8003.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8284.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03518\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1328\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2b catalytic subunit, beta isoform (ec 3.1.3.16) (calmodulin-dependent calcineurin a subunit, beta isoform) (cam-prp catalytic subunit). [source:swissprot;acc:p16299]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5656.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6111.84\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08044\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosinase-related gene segment, exon 5 (fragment). [source:sptrembl;acc:q15677]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7706.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7978.04\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03517\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1329\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
5,6-dihydroxyindole-2-carboxylic acid oxidase precursor (ec 1.14.18.-) (dhica oxidase) (tyrosinase-related protein 1) (trp-1) (trp1) (trp) (catalase b) (glycoprotein-75) (melanoma antigen gp75). [source:swissprot;acc:p17643]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7708.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7979.28\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2b catalytic subunit, gamma isoform (ec 3.1.3.16) (calmodulin-dependent calcineurin a subunit, gamma isoform) (calcineurin, testis-specific catalytic subunit) (cam-prp catalytic subunit). [source:swissprot;acc:p48454]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5656.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6111.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08043\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1330\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dopachrome tautomerase precursor (ec 5.3.3.12) (dt) (dct) (dopachrome delta-isomerase) (tyrosinase-related protein 2) (trp-2) (trp2). [source:swissprot;acc:p40126]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7708.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7979.19\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03517\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
isoleucyl-trna synthetase, cytoplasmic (ec 6.1.1.5) (isoleucine--trna ligase) (ilers) (irs). [source:swissprot;acc:p41252]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5779.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6244.56\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08041\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1331\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
conserved oligomeric golgi complex component 6. [source:swissprot;acc:q9y2v7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7962.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8241.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03514\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transaldolase (ec 2.2.1.2). [source:swissprot;acc:p37837]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5799.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6265.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08034\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1332\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
my016 protein. [source:sptrembl;acc:q9h3k6]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4775.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5158.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08033\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosinase precursor (ec 1.14.18.1) (monophenol monooxygenase) (tumor rejection antigen ab) (sk29-ab) (lb24-ab). [source:swissprot;acc:p14679]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7713.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7984.28\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03514\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1333\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
abl-interactor 2; abl-interacting protein 1 (sh3-containing protein); abl binding protein 3; arg protein tyrosine kinase-binding protein; abl-interactor protein 2b; similar to spectrin sh3 domain binding protein 1. [source:refseq;acc:nm\_005759]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5803.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6269.44\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0802\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-protein ligase nedd4-like; neural precursor cell expressed, developmentally down-regulated gene 4-like; potential epithelial sodium channel regulator; homolog of yeast ubiquitin-protein ligase rsp5. [source:refseq;acc:nm\_015277]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8081.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8364.97\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0351\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1334\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribokinase (ec 2.7.1.15). [source:swissprot;acc:q9h477]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8097\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8381.01\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03508\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
spectrin sh3 domain binding protein 1; eps8 binding protein; interactor protein ablbp4; abl-interactor protein 1 long; nap1 binding protein. [source:refseq;acc:nm\_005470]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5804.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6270.15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08018\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1335\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
coatomer beta subunit (beta-coat protein) (beta-cop). [source:swissprot;acc:p53618]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
10430.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9656.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08014\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
hepatoma-derived growth factor-related protein 2. [source:refseq;acc:nm\_032631]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
8165.01\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
8451.45\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03508\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1336\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cgi-142; hepatoma-derived growth factor 2. [source:refseq;acc:nm\_016073]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
g1 to s phase transition protein 1 homolog (gtp-binding protein gst1-hs). [source:swissprot;acc:p15170]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6140.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6632.24\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08014\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1337\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
gtp cyclohydrolase i (ec 3.5.4.16) (gtp-ch-i). [source:swissprot;acc:p30793]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4935.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5329.93\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0799\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pc4 and sfrs1 interacting protein 2; pc4 and sfrs1 interacting protein 1; transcriptional coactivator p52/p75. [source:refseq;acc:nm\_033222]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8165.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8451.45\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03508\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/